Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297256 · ClinicalTrials.gov registry record · NA
Prospective Study of Thoracolumbar Spinal Fusion Graft
A NA study of Lumbar Degenerative Disc Disease, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 3
- Study locations
NCT02297256 is a NA study of Lumbar Degenerative Disc Disease that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 17 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT02297256, a NA study of Lumbar Degenerative Disc Disease, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.
Conditions Studied
Interventions
- PROCEDURE Iliac Crest Bone Graft
- PROCEDURE BMAC & Allograft
Study Locations (3)
New York
- NYU Hospital for Joint Diseases - New York
- Center for Musculoskeletal Care (CMC) - New York
- NY Spine Institute - Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-08 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02297256
The ClinicalTrials.gov registry entry for NCT02297256 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbar Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Iliac Crest Bone Graft is the first listed.
NCT02297256 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02297256 about?
NCT02297256 is a clinical study titled "Prospective Study of Thoracolumbar Spinal Fusion Graft". This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.
What is the current status of trial NCT02297256?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2012-08. Estimated completion is 2025-12-01.
What conditions does trial NCT02297256 study?
This clinical trial studies the following conditions: Lumbar Degenerative Disc Disease.
What interventions are being tested in trial NCT02297256?
The interventions under investigation include: Iliac Crest Bone Graft (PROCEDURE), BMAC & Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT02297256?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02297256 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.